Let $A\in(-\infty,+\infty]$ and $\Phi$ be a continuously on $[\sigma_0,A)$ function such that $\Phi(\sigma)\to+\infty$ as $\sigma\to A-0$. We establish a necessary and sufficient condition on a nonnegative sequence $\lambda=(\lambda_n)$, increasing to $+\infty$, under which the equality$$\overline{\lim\limits_{\sigma\uparrow A}}\frac{\ln M(\sigma,F)}{\Phi(\sigma)}=\overline{\lim\limits_{\sigma\uparrow A}}\frac{\ln\mu(\sigma,F)}{\Phi(\sigma)},$$holds for every Dirichlet series of the form $F(s)=\sum_{n=0}^\infty a_ne^{s\lambda_n}$, $s=\sigma+it$, absolutely convergent in the half-plane ${Re}\, s<A$, where $M(\sigma,F)=\sup\{|F(s)|:{Re}\, s=\sigma\}$ and $\mu(\sigma,F)=\max\{|a_n|e^{\sigma\lambda_n}:n\ge 0\}$ are the maximum modulus and maximal term of this series respectively.
Нехай $(\lambda_n)$ $-$ невід'ємна зростаюча до $+\infty$ послідовність, $\tau=\limsup\limits_{n\to\infty}\frac{\ln n}{\lambda_n}$, а $\rho$ $-$ додатне число. З класичної теореми Ж. Валірона випливає, що для кожного цілого ряду Діріхле вигляду $F(s)=\sum a_ne^{s\lambda_n}$ правильна оцінка$$\limsup_{\sigma\to+\infty}\frac{\ln \sup\{|F(s)|:\,\text{Re}\, s=\sigma\}}{e^{\rho\sigma}}\le e^{\rho\tau} \limsup_{n\to\infty}\frac{\lambda_n}{e\rho}|a_n|^\frac{\rho}{\lambda_n}.$$В роботі доведено точність цієї оцінки.
UDC 517.53For the entire Dirichlet series f (z) = X 1 n=0 ane zλn , we establish necessary and sufficient conditions on the coefficients an and exponents λn under which the function f has the Paley effect, i.e., the condition lim supis satisfied, where M f (r) and T f (r) are the maximum modulus and the Nevanlinna characteristic of the function f, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.